Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

  • Post author:
  • Post published:February 22, 2026
  • Post category:

Continue ReadingThe HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development

Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

  • Post author:
  • Post published:February 22, 2026
  • Post category:

We propose to discover new drug candidates for Alzheimer’s Disease (AD), which is common, fatal, and for which no effective disease-modifying drugs are available. Because no effective AD treatment is…

Continue ReadingIdentifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

Direct reprogramming towards vascular progenitors for the treatment of ischemia

  • Post author:
  • Post published:February 22, 2026
  • Post category:

Angiogenesis or the generation of new blood vessels is a critical part of the normal healing process. Newly created vessels ensure the delivery of oxygen, nutrients, and specific repair signals…

Continue ReadingDirect reprogramming towards vascular progenitors for the treatment of ischemia

Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

  • Post author:
  • Post published:February 22, 2026
  • Post category:

Autophagy is the cells mechanism for breaking down and recycling proteins. Danon disease is an inherited disorder of autophagy. Patients with this disease have major abnormalities in heart and skeletal…

Continue ReadingIdentification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons

  • Post author:
  • Post published:February 22, 2026
  • Post category:

Approximately 5,600 people in the U.S. are diagnosed with ALS each year. The incidence of ALS is two per 100,000 people, and it is estimated that as many as 30,000…

Continue ReadingMolecules to Correct Aberrant RNA Signature in Human Diseased Neurons
  • Go to the previous page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us